GCIAptamer Group: Turner Pope
(APTA) has undertaken a firm and conditional equity placing and subscription (‘the Placing’), raising £2.83m (gross) funding through placement of 1,415m new ordinary shares priced at 0.2p each. This follows the recent flurry of high margin Fee-For-Service (‘FFS’) contracts with Big Pharma and a major consumer goods company which have pushed the Group’s order book up to c.£1.8m, while its pipeline of further opportunities has risen to c.£2.1m.
Accompanying this improved momentum, the Group is now also proposing Boardroom changes that will be ratified at the forthcoming General Meeting (‘GM’). This will see its co-founder and current CTO reassume the role of CEO, with ambition to place increased focus back on asset development and licensing in anticipation of crystallising much higher-value inflection points for shareholders. Changing emphasis away from relatively predictable FFS operations will, of course, raise Aptamer’s risk profile, although Directors stress a good level of confidence in its ability to capture significantly greater, highly visible longer-term returns through accrual of downstream milestone payments, licensing fees and/or royalties as partnered projects approach and achieve commercialisation.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.